Korean MFSD publishes Revision 7 of Comparative Dissolution Test Guideline

Recommendation
6/7 May 2025
Challenges and Solutions for Packaging / Devices & Single Use Systems
The Korean Ministry of Food and Drug Safety (MFDS) has revised the "Guidelines for Comparative Dissolution Test (Guideline for Civil Petitioners)". A new version (revision 7) dated 18 May 2023 was published.
The document is divided into the following main chapters:
- Overview
- Considerations when Determining the Equivalence of Comparative Dissolution Test Data
- Comparative Dissolution Test Result Report Standard Format
- References
According to the English translation of chapter 1, "the purpose of this guideline is to help applicants or reviewers understand as reference data for preparation of comparative dissolution test result reports required when applying for pharmaceutical product approval/notification (including changes). [...] This guideline is applied to items subject to comparative dissolution testing for new items for approval and notification of pharmaceuticals and items with changes in approval items."
Compared to the previous version, which was published in 2021, the new document contains additional considerations and references when determining equivalence of comparative dissolution test.
The revised guideline in Korean language can be found as a PDF file on the website of the Ministry of Food and Drug Safety.
Related GMP News
12.03.2025EMA publishes Considerations regarding the Implementation of ICH M13A on Bioequivalence
12.03.2025Proposed Update to USP <1058> on Analytical Instrument and System Qualification
06.03.2025Eurachem publishes Leaflet on Analytical Equipment and Systems
06.03.2025Further Modifications to USP Chapter <621> Chromatography Published for Comment
26.02.2025FDA Warning Letter Highlights Responsibilities of Contract Testing Laboratories
26.02.2025New ISO/TR 33402:2025 on Reference Material Preparation